מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
BISOPROLOL FUMARATE
Accord Healthcare Ireland Ltd.
C07AB; C07AB07
BISOPROLOL FUMARATE
10 milligram(s)
Tablet
Product subject to prescription which may be renewed (B)
Beta blocking agents, selective; bisoprolol
Not marketed
2018-01-26
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Bisoprolol fumarate 5 mg, tablets Bisoprolol fumarate 10 mg, tablets Bisoprolol fumarate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Bisoprolol fumarate is and what it is used for 2. What you need to know before you take Bisoprolol fumarate 3. How to take Bisoprolol fumarate 4. Possible side effects 5. How to store Bisoprolol fumarate 6. Contents of the pack and other information 1. WHAT BISOPROLOL FUMARATE IS AND WHAT IT IS USED FOR Bisoprolol fumarate belongs to a group of medicinal products called beta-blockers. It is used to treat: - high blood pressure - angina pectoris (pain in the chest caused by blockages in the arteries leading to the heart). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BISOPROLOL FUMARATE DO NOT TAKE BISOPROLOL FUMARATE: - if you are ALLERGIC to bisoprolol fumarate or any of the other ingredients of this medicine (listed in section 6) - if you suffer from SEVERE ASTHMA or from other SEVERE breathing difficulties - if you have ACUTE HEART FAILURE or are in shock caused by heart problems - if you suffer with HEART CONDUCTION or RHYTHM PROBLEMS (2nd or 3rd degree AV-block, sick sinus syndrome or sinoatrial block) - if you have a SLOW HEART RATE of less than 60 beats per minute before starting treatment - if you have LOW BLOOD PRESSURE - if you suffer from severely BLOCKED BLOOD VESSELS, including BLOOD CIRCULATION PROBLEMS (which may cause your fingers and toes to tingle or turn pale or blue) - if קרא את המסמך השלם
Health Products Regulatory Authority 30 October 2019 CRN00998H Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Bisoprolol Fumarate 10mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet Bisoprolol fumarate 10 mg contains 8.49 mg bisoprolol equivalent to 10 mg bisoprolol fumarate. Excipient with known effect Each tablet contains 130.20 mg of lactose monohydrate per tablet For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. Bisoprolol fumarate 10 mg tablets are mottled beige, round and convex with the following identification markings: BI centrally above a break-line with 10 below. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertension Chronic stable angina pectoris 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dosage should be individually adjusted. It is recommended to start with the lowest possible dose. In some patients, 5 mg per day may be adequate. The usual dose is 10 mg once daily with a maximum recommended dose of 20 mg per day. _Special Populations_ _Renal or liver impairment_ Adjustment of dose in patients with mild to moderate liver- or kidney impairment is usually not necessary. In patients with severe renal impairment (creatinine clearance < 20 ml/min) or severe liver impairment, the dose should not exceed 10 mg once daily. This dosage may eventually be divided into halves. _Elderly_ No dosage adjustment is normally required. It is recommended to start with the lowest possible dose. _Paediatric population_ Bisoprolol fumarate tablets are not recommended for use in children due to a lack of data (see section 5.3). _Discontinuation of treatment_ Treatment should not be stopped abruptly (see section 4.4). The dosage should be diminished slowly by a weekly halving of the dose. Method of administration Health Products Regulatory Authority 30 October 2019 CRN00998H Page 2 of 9 Bisoprolol fumarate tablets are for oral administration. The tablet should be swallowed with a suffic קרא את המסמך השלם